These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

220 related items for PubMed ID: 8943212

  • 1. Insulin- and mitogen-activated protein kinase-mediated phosphorylation and activation of peroxisome proliferator-activated receptor gamma.
    Zhang B, Berger J, Zhou G, Elbrecht A, Biswas S, White-Carrington S, Szalkowski D, Moller DE.
    J Biol Chem; 1996 Dec 13; 271(50):31771-4. PubMed ID: 8943212
    [Abstract] [Full Text] [Related]

  • 2. Activation of MEK/ERK signaling promotes adipogenesis by enhancing peroxisome proliferator-activated receptor gamma (PPARgamma ) and C/EBPalpha gene expression during the differentiation of 3T3-L1 preadipocytes.
    Prusty D, Park BH, Davis KE, Farmer SR.
    J Biol Chem; 2002 Nov 29; 277(48):46226-32. PubMed ID: 12270934
    [Abstract] [Full Text] [Related]

  • 3. Insulin regulation of mitogen-activated protein kinase kinase (MEK), mitogen-activated protein kinase and casein kinase in the cell nucleus: a possible role in the regulation of gene expression.
    Kim SJ, Kahn CR.
    Biochem J; 1997 May 01; 323 ( Pt 3)(Pt 3):621-7. PubMed ID: 9169593
    [Abstract] [Full Text] [Related]

  • 4. Insulin induction of protein kinase C alpha expression is independent of insulin receptor Tyr1162/1163 residues and involves mitogen-activated protein kinase kinase 1 and sustained activation of nuclear p44MAPK.
    Antoine PJ, Bertrand F, Auclair M, Magré J, Capeau J, Cherqui G.
    Endocrinology; 1998 Jul 01; 139(7):3133-42. PubMed ID: 9645686
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of adipogenesis through MAP kinase-mediated phosphorylation of PPARgamma.
    Hu E, Kim JB, Sarraf P, Spiegelman BM.
    Science; 1996 Dec 20; 274(5295):2100-3. PubMed ID: 8953045
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Tumor necrosis factor alpha-mediated insulin resistance, but not dedifferentiation, is abrogated by MEK1/2 inhibitors in 3T3-L1 adipocytes.
    Engelman JA, Berg AH, Lewis RY, Lisanti MP, Scherer PE.
    Mol Endocrinol; 2000 Oct 20; 14(10):1557-69. PubMed ID: 11043572
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Modulation of insulin receptor substrate-1 tyrosine phosphorylation and function by mitogen-activated protein kinase.
    De Fea K, Roth RA.
    J Biol Chem; 1997 Dec 12; 272(50):31400-6. PubMed ID: 9395471
    [Abstract] [Full Text] [Related]

  • 15. The p42/p44 mitogen-activated protein kinase cascade is determinant in mediating activation of the Na+/H+ exchanger (NHE1 isoform) in response to growth factors.
    Bianchini L, L'Allemain G, Pouysségur J.
    J Biol Chem; 1997 Jan 03; 272(1):271-9. PubMed ID: 8995258
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Caveolin-mediated regulation of signaling along the p42/44 MAP kinase cascade in vivo. A role for the caveolin-scaffolding domain.
    Engelman JA, Chu C, Lin A, Jo H, Ikezu T, Okamoto T, Kohtz DS, Lisanti MP.
    FEBS Lett; 1998 May 29; 428(3):205-11. PubMed ID: 9654135
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.